The Emerging Therapeutic Promise of SGLT2 Inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease
Wenjing Zhang, Huaidong Hu
Topics & Concepts
MedicineRepurposingHepatologyTransplant surgeryIntensive care medicineDiabetes mellitusLiver diseaseClinical trialDiseaseFatty liverFenofibrateType 2 diabetesKidney diseasePharmacologyInternal medicineMEDLINEBioinformaticsTherapeutic approachPioglitazoneSteatosisAtherosclerotic cardiovascular diseaseNephrologyType 2 Diabetes MellitusPrecision medicineLiver transplantationLiver Disease Diagnosis and TreatmentDiabetes Treatment and ManagementLiver Disease and Transplantation